Paul Hopper Net Worth

What's Paul Hopper's mailing address?

Paul's mailing address filed with the SEC is 101/50 MCLACHLAN AVENUE, , RUSHCUTTERS BAY, C3, 2011.

Insiders trading at Scopus Biopharma

Over the last 4 years, insiders at Scopus Biopharma have traded over $0 worth of Scopus Biopharma stock and bought 21,190 units worth $148,408 . The most active insiders traders include Ira Scott Greenspan, Joshua R Lamstein a Robert J Gibson. On average, Scopus Biopharma executives and independent directors trade stock every 12 days with the average trade being worth of $0. The most recent stock trade was executed by Ira Scott Greenspan on 27 August 2021, trading 900 units of SCPS stock currently worth $4,473.

What does Scopus Biopharma do?

Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development programs are immuno-oncology gene therapy for the treatment of various cancers, which include CO-sTiRNA, a STAT3 inhibitor gene therapy that drives tumor cell growth and anti-tumor immune suppression; and MRI-1867, a cannabinoid-1 receptor inverse agonist and inhibitor of inducible nitric oxide synthase for the treatment of systemic sclerosis. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.

Scopus Biopharma executives and stock owners

Scopus Biopharma executives and other stock owners filed with the SEC include:

• Ira Scott Greenspan,
  Sr. Advisor & Director
• Dr. Morris C. Laster,
  Co-Chairman & CEO
• Daniel J. Politzer C.F.A.,
  CFO & COO
• Robert J. Gibson,
  Vice Chairman, Sec. & Treasurer
• Alan D. Horsager Ph.D.,
  Pres?of?Immuno-Oncology and Pres & CEO of Olimmune Inc.
• Dr. Alan M. Horsager Ph.D.,
  Pres
• David Silberg,
  Sr. Advisor
• Ashish Pradip Sanghrajka,
  Pres & Director
• Robert J Gibson,
  Vice Chairman
• Ira Scott Greenspan,
  Executive Committee Chairman
• Joshua R Lamstein,
  Chairman
• Paul Hopper,
  Director